Document is current
Any future updates will be listed below
-
Authors
Duncombe, Caroline J. https://orcid.org/0000-0002-4356-6317
Sen, Nilasha
Watson, Felicia N. https://orcid.org/0000-0003-1468-5648
Poehlman, Alen S.
Layton, Erik D. https://orcid.org/0000-0001-6409-290X
Boey, Kenneth https://orcid.org/0000-0002-6329-2333
Conrad, Ethan N.
Kalata, Anya C.
Seilie, A. Mariko
Dill-McFarland, Kimberly A. https://orcid.org/0000-0003-1481-7065
Seshadri, Chetan https://orcid.org/0000-0003-2783-7540
Shears, Melanie J. https://orcid.org/0000-0002-8226-4354
Murphy, Sean C. https://orcid.org/0000-0002-2048-0131
-
Funding
Funding for this research was provided by:
National Science Foundation (1000341692)
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 19 May 2025
First Online: 4 June 2025
Competing interests
: C.J.D., N.S., F.N.W., A.S.P., E.D.L., K.B., E.N.C, A.C.K., A.M.S, C.S. and M.J.S. declare no competing interests. S.C.M. filed a patent application on selected aspects of the prime-and-trap concept through the University of Washington. S.C.M. has equity in a startup company (Sound Vaccines, Inc.) that is negotiating with the University of Washington for rights to this intellectual property. The relationship between the authors and Sound Vaccines, Inc., has been reviewed by the University of Washington and complies with all University and State of Washington policies on such activities. K.A.D. is a paid contractor for Seattle Biosoftware, which had no input or association with this study.
